clinical trial · NCT07279155
A Study on the Bioequivalence of Bupivacaine Liposome Injection in Humans
Jiangsu HengRui Medicine Co., Ltd.·phase1·completed·n = 36
Postoperative Local AnalgesiaBupivacaine Liposome Injection T preparationBupivacaine Liposome Injection R preparation
brief summary
This study aims to investigate the pharmacokinetics of bupivacaine liposomal injection (test preparation) in healthy subjects. The manufactured liposomal bupivacaine injection (EXPAREL®) was used as the reference formulation to evaluate the human bioequivalence between the two formulations.
started
Jun 9, 2025
primary completion
Jul 21, 2025
completion
Jul 21, 2025
last updated
Dec 12, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol